Cartesian Therapeutics Inc’s filing revealed that its Director SPRINGER TIMOTHY A acquired Company’s shares for reported $11398.0 on Mar 18 ’24. In the deal valued at $0.60 per share,19,044 shares were bought. As a result of this transaction, SPRINGER TIMOTHY A now holds 31,073,406 shares worth roughly $839.29 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, SPRINGER TIMOTHY A bought 800 shares, generating $488 in total proceeds. Upon buying the shares at $0.61, the Director now owns 104,818 shares.
Before that, SPRINGER TIMOTHY A bought 537,500 shares. Cartesian Therapeutics Inc shares valued at $314,545 were divested by the Director at a price of $0.59 per share. As a result of the transaction, SPRINGER TIMOTHY A now holds 31,054,362 shares, worth roughly $838.78 million.
Oppenheimer initiated its Cartesian Therapeutics Inc [RNAC] rating to an Outperform in a research note published on June 04, 2024; the price target was $50. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. H.C. Wainwright also remained covering RNAC and reiterated its “Buy” recommendation on April 23, 2024. Leerink Partners started covering the stock on April 23, 2024. It rated RNAC as “an Outperform”.
Price Performance Review of RNAC
On Friday, Cartesian Therapeutics Inc [NASDAQ:RNAC] saw its stock fall -5.29% to $27.01. Over the last five days, the stock has gained 18.46%. Cartesian Therapeutics Inc shares have risen nearly 30.60% since the year began. Nevertheless, the stocks have fallen -16.64% over the past one year. While a 52-week high of $42.60 was reached on 06/06/24, a 52-week low of $11.66 was recorded on 04/08/24. SMA at 50 days reached $25.81, while 200 days put it at $25.54. A total of 0.59 million shares were traded, compared to the trading of 0.14 million shares in the previous session.
Levels Of Support And Resistance For RNAC Stock
The 24-hour chart illustrates a support level at 25.73, which if violated will result in even more drops to 24.46. On the upside, there is a resistance level at 28.65. A further resistance level may holdings at 30.30. The Relative Strength Index (RSI) on the 14-day chart is 50.55, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.50, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.92%. Stochastics%K at 33.43% indicates the stock is a holding.
